Furthermore, both acute and chronic administration of FGF21 increased circulating adiponectin levels, and adiponectin deficiency diminished the metabolic effects of FGF21 on glucose tolerance and insulin resistance 71. This evidence concerns the gene ADIPOQ and Insulin resistance.